Abstract 6P
Background
Lymph nodes (LN) act as central hubs for the orchestration of adaptive immune responses. A network of lymph node stromal cells (LNSC), including mesenchymal and endothelial cells, build a 3D network for immune cells to migrate and home to distinct niches in the LN. Within B cell non-Hodgkin lymphomas, indolent follicular lymphomas (FL) are characterized by subtle structural changes while the compartmentalization of the tissue remains present. In contrast, aggressive diffuse large B cell lymphomas (DLBCL) are defined by a complete loss of tissue organization indicating a potential role of LNSCs in tumorigenesis. While the morphological differences are well-known, the underlying molecular and cellular mechanisms remain poorly understood.
Methods
Here, we dissect the mechanisms underlying loss of structure in lymphomagenesis using combined single-cell transcriptome and spatially-resolved mapping approaches of LNSCs and immune cells.
Results
Using ultra-high plex immunofluorescence imaging, we characterized how lymph node cells organize into spatially distinct cellular neighborhoods, the disruption of which was congruent with lymphoma-induced remodeling. Using single-cell transcriptome data, we investigated the molecular programs driving this loss of organization. In DLBCL, chemokines relevant for immune cell organization were downregulated, while chemokines contributing to inflammation were upregulated, suggesting a phenotypic switch from a structural organized to an inflammatory and fibrotic state. In silico cell-cell interaction analysis indicated that besides the loss of mesenchyme-derived chemokine gradients, inflammatory immune cells outside of follicles turn into ectopic sources of these chemokines, an effect which likely contributes to the diffuse growth pattern of aggressive lymphomas. High expression of organizing chemokines was associated with better overall survival, this association being significant in FL and a trend in DLBCL.
Conclusions
Collectively, these data suggest that a reprogramming of the LN microenvironment triggers an imbalance in chemokine gradients, which underlies loss of tissue organization in aggressive lymphomas.
Clinical trial identification
Editorial acknowledgement
Legal entity responsible for the study
The authors.
Funding
Has not received any funding.
Disclosure
All authors have declared no conflicts of interest.
Resources from the same session
89P - Cold atmospheric plasma-activated fluids as a potential new intravesical agent for the treatment of bladder cancer
Presenter: Maria Filomena Botelho
Session: Poster session 09
90P - Discovery of CMPD1 as a tumor-specific cytotoxic microtubule inhibitor
Presenter: Mamoru Takada
Session: Poster session 09
91P - Erythroid precursor-differentiated myeloid cells promote pulmonary metastasis in hepatocellular carcinoma
Presenter: Wei-hang Zhu
Session: Poster session 09
92P - Discovery of novel AXL and MER inhibitors as potential anticancer and immune modulator drugs
Presenter: Hsing-Pang Hsieh
Session: Poster session 09
93P - Transcriptome changes of immune cells across chemotherapy of triple-negative breast cancer
Presenter: Tatiana Gerashchenko
Session: Poster session 09
509P - Spatial analysis of tumor-associated macrophages within the tumor microenvironment of primary tumors and matched brain metastases
Presenter: Markus Kleinberger
Session: Poster session 09
510P - CD47 regulates cellular and metabolic plasticity in glioblastoma
Presenter: Ruhi Polara
Session: Poster session 09
511P - Immunodisruptive conditions and glioma diagnosis: 24-year retrospective study of an under-recognized scenario
Presenter: Santiago Cabezas-Camarero
Session: Poster session 09
512P - Heterozygous germline Fanconi anemia-related gene mutations increase susceptibility to central nervous system germ cell tumors
Presenter: Guangyu Wang
Session: Poster session 09
513P - Cyclin pathway in oligodendrogliomas IDH mut and 1p/19q codeleted
Presenter: Maria Angeles Vaz Salgado
Session: Poster session 09